Evidence map›Paper›PMID 31291289›Full record

ArticlePloS one2019

A fully automated sample-to-answer PCR system for easy and sensitive detection of dengue virus in human serum and mosquitos.

Jih-Jin Tsai, Wei-Liang Liu, Ping-Chang Lin, Bo-Yi Huang, Ching-Yi Tsai, Pei-Yu Alison Lee, Yun-Long Tsai, Pin-Hsing Chou, Simon Chung, Li-Teh Liu and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Rapid Detection ofInternational journal of molecular sciences · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jih-Jin TsaiCenter for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.ORCID 0000-0003-2226-8916
Wei-Liang LiuNational Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Zhunan, Taiwan.
Ping-Chang LinCenter for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Bo-Yi HuangCenter for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Ching-Yi TsaiCenter for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Pei-Yu Alison LeeGeneReach Biotechnology, Taichung, Taiwan.
Yun-Long TsaiGeneReach Biotechnology, Taichung, Taiwan.
Pin-Hsing ChouGeneReach Biotechnology, Taichung, Taiwan.
Simon ChungGeneReach Biotechnology, Taichung, Taiwan.
Li-Teh LiuCenter for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chun-Hong ChenNational Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Zhunan, Taiwan.
Kaohsiung Medical University · TWNational Health Research Institutes · TWChung Hwa University of Medical Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe insulated isothermal PCR (iiPCR) technology enables consistent PCR amplification and detection in a simple heating device. A pan-dengue virus (DENV) RT-iiPCR, targeting the 5' untranslated region, was validated previously on the semi-automated POCKIT combo system (involving separate devices for nucleic acid extraction and PCR amplification/detection) to offer performance comparable to a laboratory real-time PCR. Working on the same technologies, a compact automated sample-in-answer-out system (POCKIT Central Nucleic Acid Analyser) has been available commercially for iiPCR, minimizing human error risks and allowing easy molecular bio-detection near points of need. Here, we evaluated the analytical and clinical performance of the pan-DENV RT-iiPCR on the fully automated system by comparison to those on the semi-automated system. METHODOLOGY/PRINCIPAL

findingsTesting sera containing serial diluted DENV-1, -2, -3, or -4 cell culture stock, the pan-DENV RT-iiPCR system had similar 100% detection endpoints on the two systems; i.e. at 1, 10, 1 and 10 PFU/ml, respectively, on the fully automated system, and at 10, 1, 10 and 10 PFU/ml, respectively, on the semi-automated system. Furthermore, both fully automated and semi-automated PCR system can detect all four DENV serotypes in mosquitos. Clinical performance of the reagent on the two systems was evaluated by testing 60 human serum samples. Both systems detected the same 40 samples (ten DENV-1, -2, -3, and -4 positive each) and did not detect the other 20; 100% agreement (κ = 1) was found between the two systems. CONCLUSIONS/SIGNIFICANCE: With performance comparable to a previously validated system, the fully-automated PCR system allows applications of the pan-DENV reagent as a useful tool near points of need to facilitate easy, fast and effective detection of dengue virus and help mitigate versatile public health challenges in the control and management of dengue disease.

Indexed as

AdultAgedAnimalsCulicidaeDengueDengue VirusFemaleHumansMaleMiddle AgedPoint-of-Care SystemsPolymerase Chain ReactionYoung Adult

Identifiers

PMID31291289
PMCPMC6619671
OpenAlexW2959864620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.